Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.42B | 7.78B | 7.32B | 5.55B | 4.86B | Gross Profit |
2.00B | 1.95B | 1.56B | 1.37B | 1.28B | EBIT |
1.36B | 1.43B | 951.40M | 1.01B | 895.73M | EBITDA |
1.36B | 2.06B | 1.53B | 1.53B | 1.31B | Net Income Common Stockholders |
911.90M | 933.20M | 575.60M | 670.80M | 584.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
559.70M | 931.10M | 161.40M | 235.00M | 1.20B | Total Assets |
17.10B | 14.55B | 14.23B | 13.68B | 11.69B | Total Debt |
5.83B | 4.39B | 4.52B | 4.52B | 3.69B | Net Debt |
5.27B | 3.45B | 4.36B | 4.29B | 2.49B | Total Liabilities |
8.96B | 7.04B | 7.28B | 7.11B | 5.66B | Stockholders Equity |
8.12B | 7.48B | 6.93B | 6.54B | 6.03B |
Cash Flow | Free Cash Flow | |||
806.10M | 664.20M | 535.60M | 560.60M | 708.16M | Operating Cash Flow |
1.41B | 1.54B | 1.15B | 1.01B | 1.07B | Investing Cash Flow |
-2.81B | -163.50M | -1.05B | -1.87B | -381.51M | Financing Cash Flow |
1.06B | -585.60M | -175.20M | -94.30M | 234.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £66.82B | 19.70 | 16.07% | 1.81% | 1.78% | 15.53% | |
72 Outperform | $31.07B | 34.33 | 11.79% | 0.78% | -4.68% | -1.73% | |
66 Neutral | $7.35B | 15.78 | 33.51% | 0.47% | 0.64% | -1.15% | |
63 Neutral | $28.07B | 14.22 | 22.83% | 0.66% | -3.56% | 70.93% | |
59 Neutral | $9.65B | 10.27 | 8.39% | 0.97% | -0.45% | -1.48% | |
47 Neutral | $2.64B | -4.00 | -31.55% | 3.33% | 2.93% | -29.90% |